1-[(1-Substituted-4-piperidinyl)methyl]-4-piperidine derivative, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
申请人:Dainippon Pharmaceutical Co., Ltd.
公开号:US06294555B1
公开(公告)日:2001-09-25
Compound of the formula (I):
wherein Ar is a group of the following formula (Ar-1) or (Ar-2):
A is a group of the formula:
—Z—N(Q1)(Q2), —CO—R7
or
—(CH2)p—CH(R8)—COR9,
or a pharmaceutically acceptable acid addition salt thereof, a process for preparing the same, a pharmaceutical composition containing the same, and intermediates therefor. The compounds of the present invention show a potent affinity for 5-HT4 receptors, and they are useful as a gastrointestinal motility enhancer or a gastrointestinal prokinetic agent.
化合物的公式(I):其中Ar是以下公式(Ar-1)或(Ar-2)的基团:A是以下公式的基团:—Z—N(Q1)(Q2)、—CO—R7或—(CH2)p—CH(R8)—COR9,或其药学上可接受的酸盐,制备该化合物的方法、含有该化合物的药物组合物,以及其中间体。本发明的化合物显示出对5-HT4受体的强大亲和力,它们可用作胃肠蠕动增强剂或胃肠促动剂。